Expression of Androgen Receptor Coregulators in Prostate Cancer and Its Value in Predicting the Prognosis of Patients after Endocrine Therapy

Hang WEN,Yifen ZHANG,Yangbo GUAN,Jun YANG,Yutian DAI
DOI: https://doi.org/10.3969/j.issn.1000-8179.2010.08.008
2010-01-01
Chinese Journal of Clinical Oncology
Abstract:Objective: To evaluate the expression levels of androgen receptor coregulators in prostate cancer and their significance in predicting the prognosis of patients treated with endocrine therapy. Methods: Clinical and pathological data of 116 cases of prostate cancer treated with endocrine therapy were collected between January 2000 and November 2007 in our hospital. The expression of steroid receptor coactivator-1 (SRC-1) and silencing mediator for retinoid and thyroid hormone receptors (SMRT) were detected with immunohistochemical EnVision method in paraffin-embeded tissue. Relation-ship of SRC-1 and SMRT expression with clinicopathologic characteristics was investigated through χ2 test or Fish exact test. Clinicopathologic factors and protein expression that influence the progression-free survival of prostate cancer patients were analyzed with univariate (log-rank test) and multivariate Cox proportional hazard model. Results: SRC-1 expression was significantly associated with several conventional prognostic factors. Univariate analysis showed that clinical stage, Gleason sum, pretreatment serum PSA level and SRC-1 expression were significant predictors for PSA progression after endocrine therapy. Multivariate analysis revealed that SRC-1 expression and clinical stage were independently correlated with PSA progression after endocrine therapy. Conclusion: SRC-1 is an independent prognostic factor for prostate cancer patients treated with endocrine therapy. Combined evaluation of SRC-1 expression and clinical stage would be particularly useful for predicting the outcome of prostate cancer patients treated with endocrine therapy.
What problem does this paper attempt to address?